Sitagliptin 100mg
Sitagliptin 100mg is a pharmaceutical drug with 19 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
12 of 12 finished
0.0%
0 ended early
2
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia
Doxycycline in Type II Diabetes
SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
Clinical Trials (19)
Effect of Dapagliflozin vs Sitagliptin on Liver Fat Accumulation and Body Composition in Patients With Diabetes Mellitus and Liver Transplantation
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia
Doxycycline in Type II Diabetes
SITAgliptin Plus GLARgine to Glycemic Control in the Hospital Setting (SITAGLAR-H)
Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients
Sitagliptin for the Treatment of Type 2 Diabetes
Semaglutide vs Sitagliptin
Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus
Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 Diabetes
Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy
Sitagliptin for the Treatment of Grade 3-4 and Refractory Acute Graft-versus-host Disease
Involvement of Dipeptidyl Peptidase-4 and Sodium-glucose Co-transporter-2 in Extrapancreatic Glucagon Secretion
The Effects of Neprilysin on Glucagon-like Peptide-1
A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin
Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus Sulfonylurea
Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes
Efficacy and Safety of Lobeglitazone Versus Sitagliptin
Safety and Efficacy of Empagliflozin (BI 10773) and Sitagliptin Versus Placebo Over 76 Weeks in Patients With Type 2 Diabetes
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19